Rabies is a viral disease that causes inflammation of the brain in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is nearly always death. The time period between contracting the disease and the start of symptoms is usually one to three months, but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.
Market Analysis and Insights: Global Rabies Diagnostics Market
The global Rabies Diagnostics market is projected to grow from US$ 1835 million in 2024 to US$ 2128 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Rabies Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rabies Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rabies Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rabies Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Rabies Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Rabies Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bio-Rad Laboratories
Merck
Thermo Fisher
Roche
BioMerieux
QIAGEN
Agilent
Creative Diagnostics
Techne
Fluidigm
Abbexa Ltd
BioNote, Inc
Norgen Biotek Corp
Aviva Systems Biology
Demeditec Diagnostics GmbH
Express Biotech International
Segment by Type
Enzyme-Linked Immunosorbent Assay (ELISA)
Polymerase Chain Reaction (PCR) Assay
Others
Segment by Application
Hospitals
Diagnostic Centers
Public Health Labs
Home Care Setting
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rabies Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rabies Diagnostics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rabies Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.3 Polymerase Chain Reaction (PCR) Assay
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rabies Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Public Health Labs
1.3.5 Home Care Setting
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rabies Diagnostics Market Perspective (2019-2030)
2.2 Global Rabies Diagnostics Growth Trends by Region
2.2.1 Rabies Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rabies Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Rabies Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Rabies Diagnostics Market Dynamics
2.3.1 Rabies Diagnostics Industry Trends
2.3.2 Rabies Diagnostics Market Drivers
2.3.3 Rabies Diagnostics Market Challenges
2.3.4 Rabies Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rabies Diagnostics by Players
3.1.1 Global Rabies Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Rabies Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Rabies Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rabies Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Rabies Diagnostics Market Concentration Ratio
3.4.1 Global Rabies Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rabies Diagnostics Revenue in 2023
3.5 Global Key Players of Rabies Diagnostics Head office and Area Served
3.6 Global Key Players of Rabies Diagnostics, Product and Application
3.7 Global Key Players of Rabies Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rabies Diagnostics Breakdown Data by Type
4.1 Global Rabies Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Rabies Diagnostics Forecasted Market Size by Type (2025-2030)
5 Rabies Diagnostics Breakdown Data by Application
5.1 Global Rabies Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Rabies Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rabies Diagnostics Market Size (2019-2030)
6.2 North America Rabies Diagnostics Market Size by Type
6.2.1 North America Rabies Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Rabies Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Rabies Diagnostics Market Share by Type (2019-2030)
6.3 North America Rabies Diagnostics Market Size by Application
6.3.1 North America Rabies Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Rabies Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Rabies Diagnostics Market Share by Application (2019-2030)
6.4 North America Rabies Diagnostics Market Size by Country
6.4.1 North America Rabies Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Rabies Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Rabies Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rabies Diagnostics Market Size (2019-2030)
7.2 Europe Rabies Diagnostics Market Size by Type
7.2.1 Europe Rabies Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Rabies Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Rabies Diagnostics Market Share by Type (2019-2030)
7.3 Europe Rabies Diagnostics Market Size by Application
7.3.1 Europe Rabies Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Rabies Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Rabies Diagnostics Market Share by Application (2019-2030)
7.4 Europe Rabies Diagnostics Market Size by Country
7.4.1 Europe Rabies Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Rabies Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Rabies Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rabies Diagnostics Market Size (2019-2030)
8.2 China Rabies Diagnostics Market Size by Type
8.2.1 China Rabies Diagnostics Market Size by Type (2019-2024)
8.2.2 China Rabies Diagnostics Market Size by Type (2025-2030)
8.2.3 China Rabies Diagnostics Market Share by Type (2019-2030)
8.3 China Rabies Diagnostics Market Size by Application
8.3.1 China Rabies Diagnostics Market Size by Application (2019-2024)
8.3.2 China Rabies Diagnostics Market Size by Application (2025-2030)
8.3.3 China Rabies Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rabies Diagnostics Market Size (2019-2030)
9.2 Asia Rabies Diagnostics Market Size by Type
9.2.1 Asia Rabies Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Rabies Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Rabies Diagnostics Market Share by Type (2019-2030)
9.3 Asia Rabies Diagnostics Market Size by Application
9.3.1 Asia Rabies Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Rabies Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Rabies Diagnostics Market Share by Application (2019-2030)
9.4 Asia Rabies Diagnostics Market Size by Region
9.4.1 Asia Rabies Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Rabies Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Rabies Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rabies Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Rabies Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Rabies Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Rabies Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Details
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Rabies Diagnostics Introduction
11.1.4 Bio-Rad Laboratories Revenue in Rabies Diagnostics Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Rabies Diagnostics Introduction
11.2.4 Merck Revenue in Rabies Diagnostics Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Rabies Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Rabies Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Rabies Diagnostics Introduction
11.4.4 Roche Revenue in Rabies Diagnostics Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Rabies Diagnostics Introduction
11.5.4 BioMerieux Revenue in Rabies Diagnostics Business (2019-2024)
11.5.5 BioMerieux Recent Developments
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Rabies Diagnostics Introduction
11.6.4 QIAGEN Revenue in Rabies Diagnostics Business (2019-2024)
11.6.5 QIAGEN Recent Developments
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent Rabies Diagnostics Introduction
11.7.4 Agilent Revenue in Rabies Diagnostics Business (2019-2024)
11.7.5 Agilent Recent Developments
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Company Details
11.8.2 Creative Diagnostics Business Overview
11.8.3 Creative Diagnostics Rabies Diagnostics Introduction
11.8.4 Creative Diagnostics Revenue in Rabies Diagnostics Business (2019-2024)
11.8.5 Creative Diagnostics Recent Developments
11.9 Techne
11.9.1 Techne Company Details
11.9.2 Techne Business Overview
11.9.3 Techne Rabies Diagnostics Introduction
11.9.4 Techne Revenue in Rabies Diagnostics Business (2019-2024)
11.9.5 Techne Recent Developments
11.10 Fluidigm
11.10.1 Fluidigm Company Details
11.10.2 Fluidigm Business Overview
11.10.3 Fluidigm Rabies Diagnostics Introduction
11.10.4 Fluidigm Revenue in Rabies Diagnostics Business (2019-2024)
11.10.5 Fluidigm Recent Developments
11.11 Abbexa Ltd
11.11.1 Abbexa Ltd Company Details
11.11.2 Abbexa Ltd Business Overview
11.11.3 Abbexa Ltd Rabies Diagnostics Introduction
11.11.4 Abbexa Ltd Revenue in Rabies Diagnostics Business (2019-2024)
11.11.5 Abbexa Ltd Recent Developments
11.12 BioNote, Inc
11.12.1 BioNote, Inc Company Details
11.12.2 BioNote, Inc Business Overview
11.12.3 BioNote, Inc Rabies Diagnostics Introduction
11.12.4 BioNote, Inc Revenue in Rabies Diagnostics Business (2019-2024)
11.12.5 BioNote, Inc Recent Developments
11.13 Norgen Biotek Corp
11.13.1 Norgen Biotek Corp Company Details
11.13.2 Norgen Biotek Corp Business Overview
11.13.3 Norgen Biotek Corp Rabies Diagnostics Introduction
11.13.4 Norgen Biotek Corp Revenue in Rabies Diagnostics Business (2019-2024)
11.13.5 Norgen Biotek Corp Recent Developments
11.14 Aviva Systems Biology
11.14.1 Aviva Systems Biology Company Details
11.14.2 Aviva Systems Biology Business Overview
11.14.3 Aviva Systems Biology Rabies Diagnostics Introduction
11.14.4 Aviva Systems Biology Revenue in Rabies Diagnostics Business (2019-2024)
11.14.5 Aviva Systems Biology Recent Developments
11.15 Demeditec Diagnostics GmbH
11.15.1 Demeditec Diagnostics GmbH Company Details
11.15.2 Demeditec Diagnostics GmbH Business Overview
11.15.3 Demeditec Diagnostics GmbH Rabies Diagnostics Introduction
11.15.4 Demeditec Diagnostics GmbH Revenue in Rabies Diagnostics Business (2019-2024)
11.15.5 Demeditec Diagnostics GmbH Recent Developments
11.16 Express Biotech International
11.16.1 Express Biotech International Company Details
11.16.2 Express Biotech International Business Overview
11.16.3 Express Biotech International Rabies Diagnostics Introduction
11.16.4 Express Biotech International Revenue in Rabies Diagnostics Business (2019-2024)
11.16.5 Express Biotech International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio-Rad Laboratories
Merck
Thermo Fisher
Roche
BioMerieux
QIAGEN
Agilent
Creative Diagnostics
Techne
Fluidigm
Abbexa Ltd
BioNote, Inc
Norgen Biotek Corp
Aviva Systems Biology
Demeditec Diagnostics GmbH
Express Biotech International
听
听
*If Applicable.
